JPMorgan said Eli Lilly is enrolling about 500,000 new obesity drug patients per month, and maintains more than 60% share in ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

That makes EPS growth an attractive quality for any company. Over the last three years, Eli Lilly has grown EPS by 12% per year. That's a good rate of growth, if it can be sustained.

Eli Lilly (LLY) ended the recent trading session at $762.18, demonstrating a -1.23% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.14% ...

Eli Lilly and Company (NYSE:LLY) Number of Hedge Fund Holders In Q2 2024: 100. Projected EPS Growth Rate: 50.6%. Eli Lilly and Company (NYSE:LLY) is a mega pharmaceutical company that sells ...

Eli Lilly projects 32% revenue growth for 2025, fueled by incretin expansion and new launches. 1mo. ... Earnings per share for 2025 are projected at $22.50 to $24.00.

Eli Lilly not only beat earnings per share (EPS) expectations with a non-GAAP EPS of $2.58 compared to the analysts' consensus figure of $2.47, but also showcased an impressive revenue increase.

Summary. Eli Lilly's shares reached new all-time highs after the company increased full-year revenue and EPS guidance. The company's growth is currently supply-constrained and the growth of ...

TD Cowen analyst Steve Scala has maintained their bullish stance on LLY stock, giving a Buy rating yesterday. Steve Scala has given his Buy rat ...

Eli Lilly and Company (NYSE:LLY) last week reported its latest yearly results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations.

But its earnings per share (EPS) could reach $6.65, ... That's a good, modest growth rate for the business. And Eli Lilly investors can expect an even better performance in 2023.

This compares with the company's previous outlook for revenue in the range of $42.4 billion to $43.6 billion and earnings per share of $13.50 to $14.00. Is Eli Lilly stock a buy, sell or hold?